Anavex Life Sciences Overview

Anavex Life Sciences Other Income Expense Net

Other Income/Expense Net for AVXL.

Quarterly Other Income/Expense

$1.12M

↑ 4.68% YoY

As of Dec 31, 2025

Annual Other Income/Expense (TTM)

$3.23M

↓ 55.14% YoY

Trailing 12 months ending Dec 31, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin